Clinical UpdatePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Novel Antipsychotics: Schizophrenia, Psychosis and Beyond CME
Author: Prakash S. Masand, MD
Medical Writer: Steffany J. Fredman
Disclosures

Release Date: December 18, 2001; Valid for credit through December 18, 2002

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.

Contents of This CME Activity
  1. Novel Antipsychotics: Schizophrenia, Psychosis and Beyond
    Introduction
    Novel Antipsychotics in Treatment of Schizophrenia
    Novel Antipsychotics in Bipolar Disorder
    Broad Spectrum of Efficacy of the Novel Antipsychotics: Focus on Dementia and Related Disorders
    Long-Term Side Effects of Novel Antipsychotics
    Antipsychotics of the Future
    Conclusion
    References


 
Legal Disclaimer
The material presented here does not reflect the views of Medical Education Collaborative, Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing medical education activity.
Copyright © 2001 Medscape

 
Astra Zeneca
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.